New Emory research study is enrolling people with depression

depression-study

The Emory University Mood and Anxiety Disorders Program is currently seeking people with depression for a research study. The purpose of this research study is to evaluate an omega-3 fatty acid supplement, in comparison to a placebo. If you are currently overweight and depressed, you may qualify for participation. All involvement is confidential and compensation may be provided for your time and travel if you qualify. The study’s duration is 12 weeks.

Mark Rapaport, MD (Emory Department of Psychiatry and Behavioral Sciences) is PI of the study, working with a team of co-investigators including Thomas Ziegler, MD, MS (Emory Division of Endocrinology, Metabolism and Lipids).

You may qualify for participation if you:

  • Are a man or woman 18-80 years old
  • Are currently depressed
  • Have a BMI greater than 30
  • Have not been diagnosed with Bipolar Disorder
  • Are able and willing to consume fish oil capsules
  • Are not using illegal drugs
  • Are not pregnant or breastfeeding

For more information call 404-778-6663 or visit the Emory Mood and Disorders Program’s website.

Related Links 

 

About the Author

Emory Department of Medicine
Emory Department of Medicine
The Emory University Department of Medicine, within the Emory University School of Medicine, is steeped in a rich tradition of excellence. Through the work of its nine divisions and numerous centers and institutes, the department has pioneered discoveries in medicine, education, scientific and clinical investigation, and clinical care. Emory University School of Medicine's medical school, residency, transitional-year, and fellowship programs offer students the latest knowledge in treatment practices, scientific theories, research, and patient care. The Emory University Department of Medicine is a component of the Robert W. Woodruff Health Sciences Center of Emory University, which includes the Emory schools of Medicine, Nursing, and Public Health; Yerkes National Primate Research Center; Winship Cancer Institute; and Emory Healthcare.
Share(s)